{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for penicillin root_names_name in Any Name (approximate match)
Status:
Investigational
Source:
NCT02877134: Phase 2 Interventional Completed Crohn Disease
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03384745: Phase 2 Interventional Completed Psoriasis
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pivekimab sunirine [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04669899: Phase 1/Phase 2 Interventional Completed Cancer
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:lorigerlimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03261739: Phase 1 Interventional Completed NAFLD
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04139902: Phase 2 Interventional Recruiting Melanoma Stage III
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:trastuzumab botidotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03700294: Phase 1 Interventional Terminated Advanced Solid Tumors
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03541369: Phase 1 Interventional Terminated Relapsed/Refractory Acute Myeloid Leukemia (AML)
(2018)
Source URL:
Class:
PROTEIN
